|
3
|
|
Population pharmacokinetics modeling of albendazole and its active metabolite, albendazole sulfoxide in mass drug administration against lymphatic filariasis.
(journals.asm.org)
|
Alshehri A
…
Murry DJ
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#pharmacokinetics
#modeling
#parasitic
#antiparasitic
#lymphatic
|
|
3
|
|
Development and validation of a cefepime population pharmacokinetic model to guide treatment for patients with hospital-acquired pneumonia requiring renal replacement.
(journals.asm.org)
|
Valadez A
…
Rhodes NJ
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#pharmacokinetics
#pneumonia
#renal replacement therapy
#modeling
#antibiotic
|
|
3
|
|
Modeling the potential effect of cabamiquine-pyronaridine for chemoprevention against Plasmodium falciparum malaria.
(journals.asm.org)
|
Okell LC
…
Okebe J
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#malaria
#chemoprevention
#pharmacokinetics
#modeling
#amr
|
|
3
|
|
Open-label Phase 1 study to evaluate drug-drug interactions between ulonivirine and islatravir in adults without HIV.
(journals.asm.org)
|
Nussbaum JC
…
Gillespie G
Antimicrobial Agents and Chemotherapy
2026-10-08
|
#pharmacokinetics
#hiv
#drug-interactions
#clinical trial
|